Want to see JP:4571 full AI Analyst Report?

NanoCarrier Co., Ltd. (4571) Price & Analysis

2 Followers

4571 Stock Chart & Stats

¥134.00

-¥1.00(-0.68%)

At close: Jan 08 4:00 PM EST

¥134.00

-¥1.00(-0.68%)

Day’s Range― - ―

52-Week Range¥93.00 - ¥254.00

Previous CloseN/A

Volume236.30K

Average Volume (3M)2.35M

Market Cap

¥7.93B

Enterprise Value¥4.90B

Total Cash (Recent Filing)¥4.91B

Total Debt (Recent Filing)¥1.60B

Price to Earnings (P/E)―

Beta0.96

Next Earnings

Aug 07, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-12.91

Shares Outstanding83,536,760

10 Day Avg. Volume484,410

30 Day Avg. Volume2,345,523

Financial Highlights & Ratios

PEG Ratio-1.32

Price to Book (P/B)3.10

Price to Sales (P/S)63.30

P/FCF Ratio0.00

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue ReboundA robust revenue rebound indicates improving commercial traction or partner-funded activity, helping validate the technology and pipeline. Sustained top-line recovery over months supports more predictable partner milestones, easing fundraising needs and strengthening long-term project viability.

High Gross MarginsConsistently very high gross margins point to strong unit economics and scalable delivery technology. Durable margins give flexibility to invest in R&D or commercial partnerships while preserving upside on product royalties, improving long-run profitability potential if volumes grow.

Partnership/Licensing Business ModelA collaboration and licensing model transfers development and commercialization risk to partners and creates milestone and royalty revenue optionality. This capital-light structure supports long-term sustainability if the company continues to secure deals and milestone payments.

Bears Say

Persistent LossesMulti-year operating and net losses erode equity and limit reinvestment capacity. Continued negative profitability suggests a long path to break-even and increases dependence on external funding; this structural loss profile is a material constraint on long-term financial resilience.

Negative Cash FlowPersistent negative operating and free cash flow force reliance on financing, potentially diluting shareholders or raising leverage. Over a multi-month horizon, lack of internal cash generation limits ability to fund trials, partner co-development, or commercialization without external support.

Rising Debt & Falling EquityMeaningful debt growth alongside falling assets and equity reduces financial flexibility and raises refinancing and interest risks. Moderate leverage today can constrain strategic choices and negotiating power with partners if clinical spend or delays require additional capital.

NanoCarrier Co., Ltd. News

Nano Holdings Begins First-in-Human mRNA Trial Targeting Knee Osteoarthritis

NanoCarrier Co., Ltd. ( ($JP:4571) ) has provided an announcement. Nano Holdings, Inc., a Japan-based healthcare value creation...

5M ago

NANO MRNA Advances RUNX1 mRNA Clinical Trial for Osteoarthritis

The latest announcement is out from NanoCarrier Co., Ltd. ( ($JP:4571) ). NANO MRNA Co., Ltd., through its...

11M ago

4571 FAQ

What was NanoCarrier Co., Ltd.’s price range in the past 12 months?

NanoCarrier Co., Ltd. lowest stock price was ¥93.00 and its highest was ¥254.00 in the past 12 months.

What is NanoCarrier Co., Ltd.’s market cap?

NanoCarrier Co., Ltd.’s market cap is ¥7.93B.

When is NanoCarrier Co., Ltd.’s upcoming earnings report date?

NanoCarrier Co., Ltd.’s upcoming earnings report date is Aug 07, 2026 which is in 6 days.

How were NanoCarrier Co., Ltd.’s earnings last quarter?

NanoCarrier Co., Ltd. released its earnings results on May 15, 2026. The company reported -¥3.84 earnings per share for the quarter, missing the consensus estimate of N/A by -¥3.84.

Is NanoCarrier Co., Ltd. overvalued?

According to Wall Street analysts NanoCarrier Co., Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does NanoCarrier Co., Ltd. pay dividends?

NanoCarrier Co., Ltd. does not currently pay dividends.

What is NanoCarrier Co., Ltd.’s EPS estimate?

NanoCarrier Co., Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does NanoCarrier Co., Ltd. have?

NanoCarrier Co., Ltd. has 83,536,760 shares outstanding.

What happened to NanoCarrier Co., Ltd.’s price movement after its last earnings report?

NanoCarrier Co., Ltd. reported an EPS of -¥3.84 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.899%.

Which hedge fund is a major shareholder of NanoCarrier Co., Ltd.?

Currently, no hedge funds are holding shares in JP:4571

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

NanoCarrier Co., Ltd.

NANO MRNA Co., Ltd. specializes in the discovery, advancement, and manufacturing of pharmaceutical products, employing its innovative micellar nanoparticle platform. Its biopharmaceutical pipeline is primarily geared towards addressing oncological conditions and a range of other severe illnesses. The enterprise also undertakes the full spectrum of activities for anti-cancer medications, from initial scientific investigation to market commercialization, all underpinned by its distinctive micellar nanoparticle approach. Established on June 14, 1996, by Kazunori Kataoka, Teruo Okano, and Ichiro Nakatomi, the firm maintains its principal operations in Tokyo, Japan.